Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury.
about
Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioningNetrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanismGene therapy for ischemic heart diseaseAkt/FOXO3a/SIRT1-mediated cardioprotection by n-tyrosol against ischemic stress in rat in vivo model of myocardial infarction: switching gears toward survival and longevityAltered Nitric Oxide System in Cardiovascular and Renal DiseasesBeyond Preconditioning: Postconditioning as an Alternative Technique in the Prevention of Liver Ischemia-Reperfusion InjuryA New Method to Stabilize C-Kit Expression in Reparative Cardiac Mesenchymal Cells.Cardiac phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxiaDifferential effects of selective and non-selective nitric oxide synthase inhibitors on the blood perfusion of ischemia-reperfused myocardium in dogs.Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liverSulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.Protective effects of nitric oxide synthase 3 and soluble guanylate cyclase on the outcome of cardiac arrest and cardiopulmonary resuscitation in mice.Novel insights into hydrogen sulfide--mediated cytoprotection.The dynamic regulation of microcirculatory conduit function: features relevant to transfusion medicine.eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex.Inorganic nitrite and chronic tissue ischaemia: a novel therapeutic modality for peripheral vascular diseases.Soluble guanylate cyclase-α1 is required for the cardioprotective effects of inhaled nitric oxide.Tetrahydrobiopterin restores diastolic function and attenuates superoxide production in ovariectomized mRen2.Lewis ratsHigh fat feeding in mice is insufficient to induce cardiac dysfunction and does not exacerbate heart failure.Baicalin protects the cardiomyocytes from ER stress-induced apoptosis: inhibition of CHOP through induction of endothelial nitric oxide synthaseIntegrative computational and experimental approaches to establish a post-myocardial infarction knowledge map.Reactive oxygen species in cardiovascular disease.Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia.Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanismEmergent role of gasotransmitters in ischemia-reperfusion injury.Ischemic postconditioning attenuates liver warm ischemia-reperfusion injury through Akt-eNOS-NO-HIF pathwayA metabolomic study of rats with doxorubicin-induced cardiomyopathy and Shengmai injection treatment.Clinical translation of nitrite therapy for cardiovascular diseases.NO-Rich Diet for Lifestyle-Related Diseases.Placental growth factor influences maternal cardiovascular adaptation to pregnancy in mice.Selective β2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia-reperfusion injury.SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats.Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer.Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury.Efficacy of gold nanoparticles against isoproterenol induced acute myocardial infarction in adult male albino rats.Hypercholesterolemia: its impact on ischemia-reperfusion injury.Induction of activating transcription factor 3 limits survival following infarct-induced heart failure in mice.Acute and chronic cardioprotection by the enkephalin analogue, Eribis peptide 94, is mediated via activation of nitric oxide synthase and adenosine triphosphate-regulated potassium channelsRedox signaling pathways involved in neuronal ischemic preconditioning
P2860
Q24336120-CC1FDA2C-F07D-4ACD-AAE0-74F0907B7DA0Q24624234-DF09E11B-1B59-41C6-A169-F8710EE47B3CQ24632135-AF81953D-46A5-4237-AF9B-C35A6237FF08Q24647370-8C370142-DA84-42B3-8F0E-0121921E2C12Q26745608-EDB00189-1E76-4539-B75F-EE4A7E073554Q26747244-59A973DA-E206-432F-9BD1-F3586DBC273BQ27330396-476CCC1C-8B56-455C-9A59-95061EE44E5AQ28278944-8473D3F3-8942-475B-8DA0-53E0166EACECQ30452703-A55B745E-A716-4DC6-9AFF-591E6C3DC951Q33743659-065F6827-6234-4E8D-9FC6-40E2D4BAAC8DQ33772589-8EADDEC3-6747-4CB4-BA0C-23A2DDF27517Q33822249-9E7399B1-2033-4DD4-AB25-E95F7DF72A25Q33830124-961F35B9-C434-43D0-8693-B17E7F1B1BC0Q34060215-ACAE4AB7-260B-497A-9548-9097800A6CD7Q34092872-E57DE5DC-7B61-4DB5-97B6-F6C4A771D18FQ34530182-78DB1B4E-B8FB-4262-B38B-3E9701098BA6Q34784680-1116D442-49B3-424E-A7B6-DCF36D997F5DQ35001320-5185EE57-0402-4486-B301-ACB17BC6E17FQ35075534-24D5DB42-C34E-430A-BC54-821106B90B79Q35092794-C2310AF3-263C-4D6D-B4E5-343C9982C930Q35126269-6C0F317E-6F12-4E36-B234-D6F8266DA3B2Q35165194-06C839F3-73CC-4894-AA6E-9464610E73CCQ35173596-A55EB33B-A458-4D15-9CEB-84FE276194BBQ35215113-6F0E5AC8-9F88-4B5F-81EB-4CD5E5979068Q35230306-D7F22850-C9E1-474E-9E8E-53E89651D660Q35321111-DA68065D-06A3-4019-A577-DFB795E154A4Q35540329-59E45976-DECE-461E-8F41-7397BAE81E75Q35566390-0745B0DF-1A2A-4500-B7CD-13BD2EF5D407Q35686746-1A726C1D-1820-4241-B8FF-03B508606C1FQ35809045-0FC39646-9C5E-4AD9-AD4C-F124FD1F7415Q35815335-0FF1D14A-1786-4814-A004-25AF2E7EE56BQ36106686-A0F3A383-D35C-4D32-ADA2-A44B303959A3Q36200567-0A7618E9-1846-4EE2-97BC-9BBBD5F60D92Q36229684-D6132CE3-A168-4BA4-8CA7-19DDD2989FF6Q36277269-5A7F0BDD-AA45-4D1F-ABE0-AD5429A5C84DQ36301960-8D22EAE7-3870-4682-8F53-B4A2AE70FE37Q36314857-C93E1D59-129E-483A-B829-8C1AA39AB6F6Q36339385-58630134-059D-46D8-BA43-88B266CF13FAQ36350926-231D1F7F-0824-4E40-832A-C0FBF80393F7Q36460627-B28FE0D9-0BB5-424E-9D74-2D5B5D50C13A
P2860
Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Endothelial nitric oxide synth ...... myocardial reperfusion injury.
@en
Endothelial nitric oxide synth ...... myocardial reperfusion injury.
@nl
type
label
Endothelial nitric oxide synth ...... myocardial reperfusion injury.
@en
Endothelial nitric oxide synth ...... myocardial reperfusion injury.
@nl
prefLabel
Endothelial nitric oxide synth ...... myocardial reperfusion injury.
@en
Endothelial nitric oxide synth ...... myocardial reperfusion injury.
@nl
P2093
P2860
P921
P1476
Endothelial nitric oxide synth ...... myocardial reperfusion injury.
@en
P2093
Aman K Kakkar
David J Lefer
James J M Greer
Michael Hicks
Mitsuhiro Yokoyama
P Derek Ware
Richard H Turnage
Rien van Haperen
Rini de Crom
Seinosuke Kawashima
P2860
P304
P356
10.1152/AJPHEART.00129.2003
P577
2003-09-11T00:00:00Z